Height and weight were measured in young patients with type 1 diabetes up t
o the age of 22 y. We found no difference between birth length standard dev
iation scores (SDS), final height SDS and target height SDS. The study grou
p of 89 diabetic boys and girls did not differ in final height from age- an
d sex-matched healthy controls. SDS for height at diagnosis, +0.17 +/- 1.10
, exceeded that for final height, -0.06 +/- 0.97 (p = 0.037). Height SDS de
creased between the ages of 11 and 18 (p < 0.01). In diabetic girls, but no
t boys, final height SDS was significantly related to mean HbA(1c), during
puberty (r = -0.40; p = 0.025). Weight gain occurred from age of menarche i
n girls with type 1 diabetes. At the age of 18, diabetic girls were 6.5 kg
heavier and had 2.7 kg/m(2) higher body mass index (BMI) than control girls
(p < 0.001). Diabetic boys were not heavier than control boys. There was a
significant relationship between mean HbA(1c) during puberty and BMI at th
e age of 18 in diabetic girls (r = 0.47; p = 0.009). In diabetic females, b
ody weight remained unchanged, HbA(1c) improved and the dose of insulin was
significantly reduced between 18 and 22 y of age. The HbA(1c) improvement
was most marked in patients with poor metabolic control. In conclusion, alt
hough mean final height was normal in young patients with type 1 diabetes,
growth was increased before diagnosis and pubertal growth spurt was reduced
. Adolescent overweight was overrepresented; it related to poor metabolic c
ontrol in females with diabetes, but showed no further acceleration in earl
y adulthood.